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The present
The web has transformed access to research results
……almost
Funded by 
the Wellcome 
Trust
……and this is why it matters
Why is open access important to the Trust?
• Web developments have created a new publishing 
model - not fully realised whilst access mediated 
through subscriptions and bundle deals.  
¾90% of NHS-funded research available online full text
¾30% immediately available to public 
¾Only 40% immediately available to NHS staff 
• Consistent with genome sequence release/access 
position
• Freely accessible dissemination of Trust-funded 
research is fundamental to our mission
• We pay for the research but do not have easy access 
to the results
Shouldn’t those who pay for the research 
be able to read it?
• Over 90% of research funded in UK 
universities is public money (government, 
research councils and charities)
“..Speak to people in the medical profession, and they 
will say the last thing they want are people who may 
have illnesses reading this information, marching into 
surgeries and asking things. We need to be careful 
with this very, very high-level information.” 
Oral evidence to House of Commons inquiry, March 
1st 2004
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Where do Trust-funded researchers publish?
Economic analysis of scientific research 
publishing 
http://www.wellcome.ac.uk/ 
scipubreport
Major concerns
• “excessive” profits: 35%+ margins
• subscription charge increases: 200% in 
last ten years - pressure on library 
budgets, reduction in number of 
subscriptions
• restrictive online access - the bundle 
deal 
• publisher retention of copyright
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Wellcome Trust 
mission?
Alternative model - open access
• The copyright holder(s) must grant to the 
public a free, irrevocable, perpetual license to 
use, copy, distribute and make derivative 
works, in any medium for any purpose. 
• A digital copy must be deposited in an open 
public archival repository (for example US 
National Library of Medicine's PubMed 
Central). 
(Bethesda meeting)
What will it cost?  
http://www.wellcome.ac.uk/ 
publications
Will it cost more?
• Whole system savings of 30%
• Estimated costs per article: 
$2,750 subscription  
$1,950 open access
With submission fee of $175, publication drops to 
$550
• Alleged charges of $10,000++ include contribution 
of funds to overheads, surplus or profit
What do authors like about current model?
• Hierarchy of journal quality
 They know which are ‘best’ journals
 They don’t pay (page charges)
 Added value: e.g. news and views, press 
releases
• Consequences of publication in ‘best’ journals
 Promotion
 Grants
 Prizes
Why are ‘best’ journals ‘best’?
• Turn down most submissions
• Provide added value (variable)
• USA (‘international’) 
• Marketing
Where is quality control?
• Referees (free)
• Editorial board (honorarium)
• Editorial staff (salaried)
Funder initiatives
• Leadership - demonstrate engagement with 
issues, join with other research funders, raise 
awareness in research community
• Fund - cost of publication (marginal to research 
costs)
• Copyright - encourage (and eventually enforce) 
author retention (involve publishers and IPR 
lawyers)
• Repository - establish open access repositories
• Evaluation - recognise intrinsic value of content 
of paper rather than title of journal
The future?
• More of the same? – unlikely
• Increased use of repositories and self- 
archiving – likely
• New open access vehicles for publishing – 
including hybrid models e.g. PNAS
• More support from funders - very likely 
e.g. Howard Hughes, Max Planck, CNRS, 
WHO ..…NIH, UK Research Councils?
• Tipping point?
The bottom line
It can not be right that access to the results 
of publicly funded research is restricted 
because the copyright to manuscripts is 
given away by researchers 
The dissemination of the results of research 
is a marginal cost and part of the costs of 
the research itself
